ORIGINAL PAPER
Nig. J. Pharm. Res. 2017, 13 (1) pp 19-25
ISSN 0189-8434
Available online at http://www.nigjpharmres.com
The suspending properties of Cissus rubiginosa fruit mucilage in
paracetamol suspension formulation
* S. N. ANYEBE1A-D, Y. E. APEJI 1E-F and O. J. OLAYEMI 2E, F
1
Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences,
Ahmadu Bello University, Zaria
2
Department of Pharmaceutical Technology and Raw Materials Development, National Institute for
Pharmaceutical Research and Development (NIPRD), Idu, Abuja
A– research concept and design; B – collection and/or assembly of data; C – data analysis and
interpretation; D – writing the article; E – critical revision of the article; F – final approval of article.
Abstract
Background: Materials with suspending properties like mucilage have been obtained from natural sources and used
to stabilize liquid formulations containing poorly dispersible solids.
Objective: The aim of this study was to evaluate the suspending properties of Cissus rubiginosa fruit mucilage
(CRM) in paracetamol oral suspension.
Materials and Methods: Paracetamol suspensions containing 0.5, 1.0, 1.5 and 2.0 %w/v CRM were prepared and
compared with suspensions formulated with same concentrations of compound tragacanth (CT). The sedimentation
volume, ease of re-dispersibility, effect of shear rate on viscosity, flow rate and drug release pattern were studied as
assessment parameters.
Results: Characterization studies of the suspensions revealed that there was a corresponding increase in the viscosity
of the suspension with increase in the concentration of the gum. Paracetamol suspension having CRM had
significantly higher viscosity (p<0.05) compared to those containing CT. The viscosities of all suspensions
decreased with increase in shear rate. There was decrease in flow rate as the viscosity of the suspension increased.
Paracetamol suspensions containing CRM were easily re-dispersible with minimum agitation at concentration less
than 1.0 %. Drug release from the suspension containing 0.5 % CRM was rapid while release from suspension
containing higher concentrations of CRM occurred at a later time, eliciting a delay in drug release.
Conclusion: This study has been able to elucidate the ability of Cissus rubiginosa fruit mucilage to act as a
suspending agent in pharmaceutical suspensions.
Keywords: Cissus rubiginosa mucilage, compound tragacanth powder, Suspension, Suspending agents
INTRODUCTION
Suspensions are defined as heterogeneous systems
consisting of two phases. The continuous or external
phase is usually liquid or semisolid while the
dispersed phase or internal phase is almost always an
insoluble solid (Singh et al., 2013). A pharmaceutical
suspension, like any other disperse system is
thermodynamically unstable, thus making it
necessary to include a stabilizer or suspending agent.
19
Anyebe et al./Nig.J.Pharm. Res. 2017, 13 (1):19-25
This reduces the rate of settling and permits easy
re-dispersion of any settled particulate matter both
by protective colloidal action and by increasing the
consistency of the suspending medium (FemiOyewo et al., 2004; Kumar et al., 2009).
Suspensions can be administered via the oral route,
topically or through the parenteral route. Formulation
of drugs as suspension for oral administration is a
convenient way to administer insoluble or poorly
soluble drugs to infants and elderly that have
difficulty swallowing tablets or capsules (Nep and
Conway, 2011).
A number of plant gums and mucilages have been
evaluated for use as suspending agents. Plant gums
exert their activity as suspending agents by
decreasing the sedimentation rate of drug particles in
suspension; this is achieved by increasing the
viscosity of the liquid vehicle thereby reducing
settling in accordance with Stoke’s law (Mahmud et
al., 2010; Uhumwangho and Ileja, 2014). Natural
gums from Albizia zygia (Femi-Oyewo et al., 2004),
Khaya senegalensis (Mahmud et al., 2010) grewia
(Nep and Conway, 2011), Katira (Singh et al., 2013),
Brachystegia eurycoma (Uhumwangho and Ileja,
2014), Chrysophyllum albidium and Albelmuscus
esculentus (Bakre and Ajakore, 2015) have been
reported to be effective for use as suspending agent in
pharmaceutical industry. Natural gums are
biodegradable, cheap, readily available, effective and
eco-friendly as compared to synthetic and semi-
synthetic materials employed as pharmaceutical
excipient (Bakre and Ajakore, 2015).
Cissus rubiginosa is a tropical plant belonging to the
family Vitaceae. It is a woody herbaceous climber
widespread found throughout tropical Africa,
growing in rocky places. Cissus rubiginosa is
commonly called rust stem vine and in
Hausa language it is called Anaya. Cissus rubiginosa
leaves has been implicated in the treatment of
dysentery and as an antidiarrheal agent in Congo and
known to possess antibacterial activity (Otshudi et
al., 2000; Fernandes and Banu, 2012).The fruit is
used in making soup in Northern Nigeria.
The present work is an attempt to investigate the
suitability of Cissus rubiginosa fruit mucilage as a
suspending agent in pharmaceutical formulations
using paracetamol. Currently, there is little or no
information on the use of Cissus rubiginosa fruit
mucilage as a suspending agent in liquid
formulations. Paracetamol was chosen for this
investigation because it is a poorly soluble drug
which would require a suspending agent to be
prepared as a liquid dosage form. The choice of
preparing paracetamol as suspension over syrup was
based on the stability profile of the two dosage forms.
Suspensions offer resistance to degradation of drugs
due to hydrolysis, oxidation or microbial activity
because it follows the zero-order kinetics. In addition,
when compared to solution dosage forms, relatively
higher concentration of drugs can be incorporated
into suspension products.
MATERIALS AND METHODS
Materials
Methods
Materials
Extraction of the mucilage
Paracetamol, compound tragacanth (BDH Chemicals,
England), benzoic acid, concentrated strawberry
syrup, chloroform water double strength, acetone
were all of analytical grade. Cissus rubiginosa fruits
were sourced from the tree growing on the rocky hills
in Nok village, Kaduna state, Nigeria. The fruit was
authenticated and given a voucher number 900330 in
the herbarium, Department of Biological Sciences,
Ahmadu Bello University, Zaria, Nigeria.
The ripe fresh fruits of Cissus rubiginosa were
cleaned, washed and sliced to remove the seed. The
succulent part of the fruit was blended and then
filtered using a muslin cloth. The mucilage was
precipitated from the filtrate using twice its volume
of acetone. The extracted mucilage was separated by
filtration, washed with distilled water and then dried
in a hot air oven at 40 °C for 4 h. The dried mucilage
obtained was powdered and stored in an airtight
bottle as CRM.
20
Anyebe et al./Nig.J.Pharm. Res. 2017, 13 (1):19-25
Preparation of paracetamol suspension
Paracetamol and CRM powders were geometrically
triturated in the mortar according to the formula in
Table 1. Chloroform water double strength (50 mL)
was added to the contents of the mortar in aliquots to
produce pourable slurry, followed by the preservative
(benzoic acid) and sweetener (Strawberry syrup)
incorporated into contents of the mortar and then
transferred into the product bottle. The volume of
suspension in the bottle was made up to 100 mL with
distilled water, shaken for about 2 min and kept for
further analysis.
Similar preparations were made at all concentrations
using compound tragacanth (CT) as suspending agent
(Table 1).
Table 1. Formula for preparing paracetamol suspensions containing CT and CRM as suspending agents
Formulation code
Ingredients
CT1
CT2 CT3 CT4
CRM1
CRM2
CRM3 CRM4
Paracetamol powder (g)
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
CT (g)
0.5
1
1.5
2
CRM (g)
0.5
1
1.5
2
Benzoic acid (mL)
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Conc. strawberry syrup (mL)
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
Chloroform water D/S (mL)
50
50
50
50
50
50
50
50
Water q.s (mL)
100
100
100
100
100
100
100
100
Evaluation of suspension
Sedimentation volume determination
The sedimentation volume of the suspensions were
determined by pouring 50 mL of each suspension
in stoppered measuring cylinder and kept
undisturbed on a flat surface at 25 ± 2 °C. The
settling volume of each suspension was inspected and
measured every 24 h for 7 days (Chaudhari et al.,
2014). The sedimentation volume (F) was calculated
using the equation below;
Ease of re-dispersibility of formulated suspension
The suspensions (50 mL) were poured into bottles,
stoppered and kept on a vibration free platform. After
7 days, the suspensions were shaken manually using
tumbling type motion 3 times to determine the ease
of re-dispersibility (Mahmud et al., 2010).
Flow rate
The flow rate was calculated as the time taken for
10 mL of the suspension to flow through a 10 mL
pipette (Sankar et al., 2010).
F =
Flow rate =
Where Vu= Final volume of sediment
Release test
Vo = Initial volume of sediment
Rheological assessment
The rheological behaviour of the prepared
suspensions were determined using Brookfield
viscometer (LVDV-1 Prime, Brookfield Engineering
Laboratories, USA). The viscosity was determined at
shear rates of 10, 20, 50, and 100 rpm. All
determinations were made in triplicates and the
results expressed as mean values.
The paddle method was used to determine the release
of drug from the formulated suspensions. Dissolution
profile of each suspension was determined at 37 0C in
500 mL simulated gastric fluid without pepsin (pH
1.2) at a paddle rotation speed of 25 rpm. Ten (10
mL) of suspension was introduced into the bottom of
the flask with a syringe and aliquots were withdrawn
after every 5 min for 30 min. An equivalent volume
of withdrawn medium was replaced with fresh
medium to maintain sink conditions. The withdrawn
21
Anyebe et al./Nig.J.Pharm. Res. 2017, 13 (1):19-25
samples were filtered and analysed for drug content
using the UV spectrophotometer at 234 nm (Mahmud
et al., 2010).
Statistical analysis
Statistical significance for viscosity and drug release
was compared using one way ANOVA (Minitab
Software Ver. 16). The test was considered to be
statistically significant, if p < 0.05
RESULTS AND DISCUSSION
Sedimentation Volume
The sedimentation volumes of the prepared
suspensions are presented in Figure 1. Sedimentation
volume was found to increase with increase in
concentration of suspending agent with the
suspensions containing CRM exhibiting more
consistency than compound tragacanth suspensions
in terms of sedimentation volume ratio. There was
rapid sedimentation of all the formulations after 3
days of storage. High sedimentation volume is an
indication that internal phase particles have settled
but the inter particle attraction and bonding were
loose and not strong enough to form hard cake during
the study period. The sedimentation volume has been
used as a measure of flocculation and highly
flocculated systems sediment to give large
sedimentation volume. This
shows
that
suspensions with CRM exhibited characteristics of
flocculated systems. Highly flocculated systems tend
to settle faster because the dispersed solid particles
have formed aggregates or flocs thereby affecting the
stability of the suspension. However, the sediment
that is formed can be easily redispersed upon
minimal shaking because the aggregates formed are
loosely bound. Flocculated systems have also been
associated with a decrease in bioavailability of the
dispersed drug due primarily to small specific area as
a result of increase in particle size of the dispersed
solid (Nutan et al., 2007).
Rheological studies
Rheological consideration is of great importance in
the study of the stability of pharmaceutical
suspensions because viscosity, as discussed under
Stokes’ law can modify the sedimentation rate.
(Uhumwangho and Ileja, 2014). Maintaining the
proper viscosity of suspensions is also important to
ensure the accuracy of dosing and ease of application.
The optimum concentration of the suspending
agent that ensures thickening of the suspension
has to be identified such that the stability is
maintained alongside the dispersibility of the
suspension (Singh et al., 2013). The viscosity of
different concentrations of the test gums are as shown
in Table 2. It was observed that there was a
corresponding increase in the viscosity of the
suspension with increase in the concentration of the
gum. The suspensions containing CRM had
significantly higher viscosity (p<0.05) than those
containing compound tragacanth. The viscosity of
formulations decreased as the speed of shearing
increased from 10 – 100 rpm (Figure 2).
This implies that with minimum agitation the
suspension will be easily re-dispersed and a stable
dose can be withdrawn. An ideal suspension should
have a high viscosity at negligible shear and low
viscosity at high shearing rate in order to aid flow
during agitation to facilitate easy pouring (Ayorinde
and Odeniyi, 2012).
The rheological studies of the suspension with
both gums shows that the suspensions are
pseudoplastic in nature. Pseudoplastic
flow
behaviour is a desirable property in suspensions
because it enhances redispersion and pourability of
the suspension prior to administration (Nutan et
al., 2007; Nep and Conway, 2011).
3.3. Re-dispersibility and flow rate
Since suspensions produce sediment on storage, it
must be easily re- dispersible for an accurate dose to
be withdrawn at any given time. Table 2 shows that
particles suspended with CRM re-dispersed easily on
agitation when the concentration was not more than
1%.
All the suspensions of CRM were seen to flow well
through the pipette (Table 3). The flow rate decreased
with increasing concentration of suspending agent
and viscosity of the suspension. A good suspension is
one that easily flows through a container allowing
uniform dose withdrawal (Bamiro et al., 2014).
22
Anyebe et al./Nig.J.Pharm. Res. 2017, 13 (1):19-25
Table 2. Properties of paracetamol suspensions formulated using CT and CRM as suspending agents
Suspending
Agent
CT
CRM
+:
++:
+++:
Formulation
Concentration
Code
(%w/v)
CT1
0.5
CT2
1.0
CT3
1.5
CT4
2.0
CRM1
0.5
CRM2
1.0
CRM3
1.5
CRM4
2.0
Not re-dispersible with cake formation
Re-dispersible with vigorous agitation
Easily re-dispersible with minimum agitation
Viscosity (m.pas
at 10 rpm)
18.2 ± 0.23
49.6 ± 0.14
63.5 ± 0.11
73.6 ± 0.26
52.3 ± 0.15
106.8 ± 0.21
347.9 ± 0.32
656.1 ± 0.19
Flow rate
(mL/s)
1.60
1.25
1.10
1.00
1.40
0.90
0.80
0.50
Re-dispersibility
+++
+++
+++
+++
+++
+++
++
++
Figure 1: Sedimentation volume of paracetamol suspension formulated with different concentrations of CT and
CRM
23
Anyebe et al./Nig.J.Pharm. Res. 2017, 13 (1):19-25
Figure 2: Effect of speed of rotation on the viscosity of paracetamol suspension formulated with different
concentrations of CT and CRM
Drug release study
The suspending agent used in suspensions can
interfere with the dissolution of the drug from the
dosage form (Manish et al., 2009).The time taken for
50 % of drug release (t50) of formulation CRM1 and
CRM2 were 13 mins and 25 mins respectively.
CRM3 and CRM4 formulations could not attain 50%
release within the study period. By increasing the
concentration of the CRM, the release rate was
decreased. This may be due to entrapment of the drug
in the polymer chain or adsorption of the polymer on
the drug particle (Azam and Haider, 2008).
Suspension containing 0.5 % mucilage (CRM1)
released over 70 % of the drug in less than 30 min
which meets the BP 2002 specification (Figure 3).
The difference in drug released by CT and CRM
suspensions compared at the same concentration was
not statistically significant at p < 0.05 except for
suspensions containing 2 % of CT and CRM (CT4
and CRM4).
CONCLUSION
The study has shown that Cissus rubiginosa fruit
mucilage has the ability to form suspensions. Hence,
the incorporation of Cissus rubiginosa fruit mucilage
Figure 3: Drug release profile of paracetamol
suspension formulated with different
concentrations of CT and CRM
at 0.5 % concentration can be exploited as an
alternative suspending agent in formulation of
pharmaceutical oral suspensions containing insoluble
solids.
24
REFERENCES
Ayorinde, J.O and Odeniyi, M.A. (2012). Evaluation of the suspending properties of new plant gum in
sulphametoxazole formulations. Int. J. Pharmacol. Pharm. Tech. 1(2): 47-50.
Azam, M.G and Haider, S.S. (2008). Evaluation of dissolution behaviour of paracetamol suspension, Dhaka Univ. J.
Pharm. Sci. 7(1):53-58.
Bakre, G. L and Ajakore, O. (2015). Suspending properties of natural gums extracted from Abelmuscus esculentus
pod and Chrysophyllum albidum fruit, Afr. J. Pharm. Pharmacol. 9(10): 321-326.
Bamiro, O.A., Ajala, T.O., Uwaezoke, O.J and Akinwumi, A.G (2014). The suspending properties of Terminalia
randii gum in magnesium carbonate suspension, Afr. J. Pharm. Pharmacol. 8(3): 87-92.
Chaudhari, P.S., Ganesh, A., Shailendra, S.S and Jeetendra, B. (2014). Evaluation of suspending and emulsifying
properties of Citrullus lanatus seeds gum, Asian J. Pharm. Clin. Res. 7(5): 181-185.
Femi-Oyewo, M.N., Adedokun, M.O and Olusoga, T. (2004). Evaluation of the suspending properties of Albizia
zygia gum on sulphadimidine suspension, Trop. J. Pharm. Res. 3 (1): 279-284.
Fernandes, G and Banu, J. (2012). Medicinal properties of plant from the genus Cissus: A review, J. Med. Plant Res.
6(6): 3080-3086.
Kumar, R., Patil, B.M., Patil, S.R and Paschapur, S.M. (2009). Evaluation of Albelmoschus esculentus mucilage as
suspending agent in paracetamol suspension, Int. J. Pharm. Res. 1: 658-665.
Mahmud, H.S., Oyi, A.R., Allagh, T.S and Gwarzo, M.S. (2010). Evaluation of the suspending property of khaya
senegalensis gum in cotrimoxazole suspension, Res. J. Appl. Sci. Eng. Tech. 2(1): 50-55.
Manish, R.B., Raju, R.T., Krodhi, G.M., Varbhav, S.A and Manish, S.K. (2009). Formulation and evaluation of
sustained release suspension of ambroxyl Hcl using ion exchange resin, Int. J. Pharm. Res. 1(4): 1322-1325.
Nep, E.I and Conway, B.R. (2011). Evaluation of grewia polysaccharide gum as a suspending agent, Int. J. Pharm.
Pharma. Sci. 3(2): 168-173.
Nutan, M.T.H., Vaithiyalingam, S.R and Khan, M.A. (2007). Controlled release multiparticulate beads coated with
starch acetate: material characterization, and identification of critical formulation and process variables,
Pharm Dev Tech, 12: 307–320.
Otshudi, L.A., Vercruysse, A and Foriers, A. (2000). Contribution to the ethnobotanical, phytochemical and
pharmacological studies of traditionally used medicinal plants in the treatment of dysentery and diarrhoea in
lomela area, Democratic Republic of Congo, J. Ethnopharmacol. 71(3): 411-423.
*Address for correspondence: Sophie N. Anyebe
Department of Pharmaceutics and
Pharmaceutical Microbiology
Faculty of Pharmaceutical Sciences
Ahmadu Bello University, Zaria
Tel: +2348036979757
Email: sophienock@yahoo.com
Conflict of Interest: None declared
Received: 8 February, 2017
Accepted: 10 May, 2017
25